Health Canada has granted approval for GlaxoSmithKline’s ( GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in ...

Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...

Celesta Capital, a global deep tech venture capital firm, today announced it is welcoming 2013 Nobel Laureate Dr. James Rothman as a Senior Advisor. Dr. Rothman will apply his expertise as a ...